Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Neoplasms of the CNS

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    June 2020
  1. MELLINGHOFF IK, Ellingson BM, Touat M, Maher E, et al
    Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.
    J Clin Oncol. 2020 Jun 12:JCO1903327. doi: 10.1200/JCO.19.03327.
    PubMed     Abstract available


    May 2020
  2. LIN NU, Borges V, Anders C, Murthy RK, et al
    Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
    J Clin Oncol. 2020 May 29:JCO2000775. doi: 10.1200/JCO.20.00775.
    PubMed     Abstract available


    April 2020
  3. ROBINSON GW, Gajjar A
    Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
    J Clin Oncol. 2020 Apr 30:JCO2000593. doi: 10.1200/JCO.20.00593.
    PubMed    


  4. MYNAREK M, von Hoff K, Pietsch T, Ottensmeier H, et al
    Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
    J Clin Oncol. 2020 Apr 24:JCO1903057. doi: 10.1200/JCO.19.03057.
    PubMed     Abstract available


    February 2020
  5. WEINER JP
    Neurocognitive Outcomes for Patients With Brain Metastasis in the Modern Era: Benefit of Treatment With Hippocampal Avoidance Whole-Brain Radiotherapy Plus Memantine.
    J Clin Oncol. 2020 Feb 14:JCO1903359. doi: 10.1200/JCO.19.03359.
    PubMed    


  6. BROWN PD, Gondi V, Pugh S, Tome WA, et al
    Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    J Clin Oncol. 2020 Feb 14:JCO1902767. doi: 10.1200/JCO.19.02767.
    PubMed     Abstract available


    January 2020
  7. AZAD NS, Gray RJ, Overman MJ, Schoenfeld JD, et al
    Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.
    J Clin Oncol. 2020;38:214-222.
    PubMed     Abstract available


    November 2019
  8. KAHALLEY LS, Peterson R, Ris MD, Janzen L, et al
    Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
    J Clin Oncol. 2019 Nov 27:JCO1901706. doi: 10.1200/JCO.19.01706.
    PubMed     Abstract available


  9. LAFAY-COUSIN L, Bouffet E, Strother D, Rudneva V, et al
    Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).
    J Clin Oncol. 2019 Nov 27:JCO1900845. doi: 10.1200/JCO.19.00845.
    PubMed     Abstract available


  10. DRAAISMA K, Chatzipli A, Taphoorn M, Kerkhof M, et al
    Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study.
    J Clin Oncol. 2019 Nov 19:JCO1900367. doi: 10.1200/JCO.19.00367.
    PubMed     Abstract available


    October 2019
  11. JEHA S, Pei D, Choi J, Cheng C, et al
    Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.
    J Clin Oncol. 2019 Oct 28:JCO1901692. doi: 10.1200/JCO.19.01692.
    PubMed     Abstract available


  12. BEGEMANN M, Waszak SM, Robinson GW, Jager N, et al
    Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma.
    J Clin Oncol. 2019 Oct 14:JCO1900577. doi: 10.1200/JCO.19.00577.
    PubMed     Abstract available


    September 2019
  13. HONG AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, et al
    Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.
    J Clin Oncol. 2019 Sep 25:JCO1901414. doi: 10.1200/JCO.19.01414.
    PubMed     Abstract available


  14. BITTERMAN DS, MacDonald SM, Yock TI, Tarbell NJ, et al
    Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.
    J Clin Oncol. 2019 Sep 9:JCO1901270. doi: 10.1200/JCO.19.01270.
    PubMed    


    June 2019
  15. REED JP, Posadas EM, Figlin RA
    Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous.
    J Clin Oncol. 2019 Jun 20:JCO1900639. doi: 10.1200/JCO.19.00639.
    PubMed    


  16. FLIPPOT R, Dalban C, Laguerre B, Borchiellini D, et al
    Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
    J Clin Oncol. 2019 Jun 13:JCO1802218. doi: 10.1200/JCO.18.02218.
    PubMed     Abstract available


    May 2019
  17. OLIVIER TW, Bass JK, Ashford JM, Beaulieu R, et al
    Cognitive Implications of Ototoxicity in Pediatric Patients With Embryonal Brain Tumors.
    J Clin Oncol. 2019 May 2:JCO1801358. doi: 10.1200/JCO.18.01358.
    PubMed     Abstract available


  18. HURVITZ SA
    Neratinib Plus Capecitabine Provides a Glimmer of Hope for a Daunting Disease.
    J Clin Oncol. 2019;37:1044-1046.
    PubMed    


    April 2019
  19. MERCHANT TE, Bendel AE, Sabin ND, Burger PC, et al
    Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.
    J Clin Oncol. 2019;37:974-983.
    PubMed     Abstract available


  20. KLUGER HM, Margolin KA, Davies MA, Long GV, et al
    Reply to A. Shinde et al.
    J Clin Oncol. 2019;37:1031-1032.
    PubMed    


    March 2019
  21. WEATHERS SP, Epner DE
    Rookie.
    J Clin Oncol. 2019;37:751-753.
    PubMed    


  22. CHANG SM, Messersmith H, Ahluwalia M, Andrews D, et al
    Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines.
    J Clin Oncol. 2019 Mar 18:JCO1802085. doi: 10.1200/JCO.18.02085.
    PubMed     Abstract available


  23. FREEDMAN RA, Gelman RS, Anders CK, Melisko ME, et al
    TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
    J Clin Oncol. 2019 Mar 12:JCO1801511. doi: 10.1200/JCO.18.01511.
    PubMed     Abstract available


    February 2019
  24. SHINDE A, Li R, Amini A, Glaser S, et al
    Can Immunotherapy Replace Radiotherapy in Melanoma Brain Metastases?
    J Clin Oncol. 2019 Feb 26:JCO1801982. doi: 10.1200/JCO.18.01982.
    PubMed    


  25. SHUEN AY, Lanni S, Panigrahi GB, Edwards M, et al
    Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
    J Clin Oncol. 2019;37:461-470.
    PubMed     Abstract available


  26. HOUILLIER C, Taillandier L, Dureau S, Lamy T, et al
    Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.
    J Clin Oncol. 2019 Feb 20:JCO1800306. doi: 10.1200/JCO.18.00306.
    PubMed     Abstract available


  27. SALLOUM R, Chen Y, Yasui Y, Packer R, et al
    Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study.
    J Clin Oncol. 2019 Feb 7:JCO1800969. doi: 10.1200/JCO.18.00969.
    PubMed     Abstract available


  28. WEN PY, Touat M, Alexander BM, Mellinghoff IK, et al
    Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
    J Clin Oncol. 2019 Feb 4:JCO1801207. doi: 10.1200/JCO.18.01207.
    PubMed     Abstract available


    January 2019
  29. COOK LB, Fuji S, Hermine O, Bazarbachi A, et al
    Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.
    J Clin Oncol. 2019 Jan 18:JCO1800501. doi: 10.1200/JCO.18.00501.
    PubMed     Abstract available


    November 2018
  30. KLUGER HM, Chiang V, Mahajan A, Zito CR, et al
    Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
    J Clin Oncol. 2018 Nov 8:JCO1800204. doi: 10.1200/JCO.18.00204.
    PubMed     Abstract available


    October 2018
  31. KALEY T, Touat M, Subbiah V, Hollebecque A, et al
    BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study.
    J Clin Oncol. 2018 Oct 23:JCO2018789990. doi: 10.1200/JCO.2018.78.9990.
    PubMed     Abstract available


  32. MEHTA MP, Kotecha R
    Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?
    J Clin Oncol. 2018 Oct 8:JCO2018793232. doi: 10.1200/JCO.2018.79.3232.
    PubMed     Abstract available


    August 2018
  33. VATNER RE, Niemierko A, Misra M, Weyman EA, et al
    Endocrine Deficiency as a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors.
    J Clin Oncol. 2018 Aug 17:JCO2018781492. doi: 10.1200/JCO.2018.78.1492.
    PubMed     Abstract available


    July 2018
  34. WU YL, Ahn MJ, Garassino MC, Han JY, et al
    CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
    J Clin Oncol. 2018 Jul 30:JCO2018779363. doi: 10.1200/JCO.2018.77.9363.
    PubMed     Abstract available


    June 2018
  35. RAMAKRISHNA N, Temin S, Chandarlapaty S, Crews JR, et al
    Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
    J Clin Oncol. 2018 Jun 25:JCO2018792713. doi: 10.1200/JCO.2018.79.2713.
    PubMed     Abstract available


  36. ZWEIG JR, Neal JW
    Infiltrating the Blood-Brain Barrier in ALK-Positive Lung Cancer.
    J Clin Oncol. 2018 Jun 25:JCO2018788554. doi: 10.1200/JCO.2018.78.8554.
    PubMed    


  37. KAYAMA T, Sato S, Sakurada K, Mizusawa J, et al
    Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.
    J Clin Oncol. 2018 Jun 20:JCO2018786186. doi: 10.1200/JCO.2018.78.6186.
    PubMed     Abstract available


    May 2018
  38. DE RUYSSCHER D, Dingemans AC, Praag J, Belderbos J, et al
    Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
    J Clin Oncol. 2018 May 22:JCO2017775817. doi: 10.1200/JCO.2017.77.5817.
    PubMed     Abstract available


  39. CAMIDGE DR, Kim DW, Tiseo M, Langer CJ, et al
    Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.
    J Clin Oncol. 2018 May 16:JCO2017775841. doi: 10.1200/JCO.2017.77.5841.
    PubMed     Abstract available


  40. HOFFMAN LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, et al
    Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
    J Clin Oncol. 2018 May 10:JCO2017759308. doi: 10.1200/JCO.2017.75.9308.
    PubMed     Abstract available


    April 2018
  41. OMURO A, Beal K, McNeill K, Young RJ, et al
    Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.
    J Clin Oncol. 2018 Apr 23:JCO2017769992. doi: 10.1200/JCO.2017.76.9992.
    PubMed     Abstract available


    February 2018
  42. FORSYTH PA, Abate-Daga D
    Oncolytic Virotherapy for Malignant Gliomas.
    J Clin Oncol. 2018 Feb 13:JCO2017773192. doi: 10.1200/JCO.2017.77.3192.
    PubMed    


  43. LANG FF, Conrad C, Gomez-Manzano C, Yung WKA, et al
    Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
    J Clin Oncol. 2018 Feb 12:JCO2017758219. doi: 10.1200/JCO.2017.75.8219.
    PubMed     Abstract available


  44. GRILL J, Massimino M, Bouffet E, Azizi AA, et al
    Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.
    J Clin Oncol. 2018 Feb 7:JCO2017760611. doi: 10.1200/JCO.2017.76.0611.
    PubMed     Abstract available


    December 2017
  45. BROWN PD, Ahluwalia MS, Khan OH, Asher AL, et al
    Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?
    J Clin Oncol. 2017 Dec 22:JCO2017759589. doi: 10.1200/JCO.2017.75.9589.
    PubMed     Abstract available


    November 2017
  46. JONES DTW, Witt O, Pfister SM
    BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma.
    J Clin Oncol. 2017 Nov 15:JCO2017758987. doi: 10.1200/JCO.2017.75.8987.
    PubMed    


  47. WANG X, Sun CL, Hageman L, Smith K, et al
    Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.
    J Clin Oncol. 2017;35:3688-3696.
    PubMed     Abstract available


    October 2017
  48. LIN NU, Prowell T, Tan AR, Kozak M, et al
    Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.
    J Clin Oncol. 2017 Oct 2:JCO2017740761. doi: 10.1200/JCO.2017.74.0761.
    PubMed     Abstract available


  49. MOK TSK, Kim SW, Wu YL, Nakagawa K, et al
    Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses.
    J Clin Oncol. 2017 Oct 2:JCO2017739250. doi: 10.1200/JCO.2017.73.9250.
    PubMed     Abstract available


    July 2017
  50. LASSALETTA A, Zapotocky M, Mistry M, Ramaswamy V, et al
    Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    J Clin Oncol. 2017 Jul 20:JCO2016718726. doi: 10.1200/JCO.2016.71.8726.
    PubMed     Abstract available


  51. WEN PY, Chang SM, Van den Bent MJ, Vogelbaum MA, et al
    Response Assessment in Neuro-Oncology Clinical Trials.
    J Clin Oncol. 2017;35:2439-2449.
    PubMed     Abstract available


  52. VAN DEN BENT MJ, Smits M, Kros JM, Chang SM, et al
    Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    J Clin Oncol. 2017;35:2394-2401.
    PubMed     Abstract available


  53. CAMPIAN J, Gutmann DH
    CNS Tumors in Neurofibromatosis.
    J Clin Oncol. 2017;35:2378-2385.
    PubMed     Abstract available


  54. MERCHANT TE
    Current Clinical Challenges in Childhood Ependymoma: A Focused Review.
    J Clin Oncol. 2017;35:2364-2369.
    PubMed     Abstract available


  55. TEEPEN JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, et al
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    J Clin Oncol. 2017;35:2288-2298.
    PubMed     Abstract available


    June 2017
  56. PARADA LF, Dirks PB, Wechsler-Reya RJ
    Brain Tumor Stem Cells Remain in Play.
    J Clin Oncol. 2017 Jun 22:JCO2017739540. doi: 10.1200/JCO.2017.73.9540.
    PubMed    


  57. MELLINGHOFF IK, Gilbertson RJ
    Brain Tumors: Challenges and Opportunities to Cure.
    J Clin Oncol. 2017 Jun 22:JCO2017742965. doi: 10.1200/JCO.2017.74.2965.
    PubMed    


  58. RAMASWAMY V, Taylor MD
    Medulloblastoma: From Myth to Molecular.
    J Clin Oncol. 2017 Jun 22:JCO2017727842. doi: 10.1200/JCO.2017.72.7842.
    PubMed     Abstract available


  59. ALEXANDER BM, Cloughesy TF
    Adult Glioblastoma.
    J Clin Oncol. 2017 Jun 22:JCO2017730119. doi: 10.1200/JCO.2017.73.0119.
    PubMed     Abstract available


  60. MACK SC, Northcott PA
    Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    J Clin Oncol. 2017 Jun 22:JCO2017729921. doi: 10.1200/JCO.2017.72.9921.
    PubMed     Abstract available


  61. SAMPSON JH, Maus MV, June CH
    Immunotherapy for Brain Tumors.
    J Clin Oncol. 2017 Jun 22:JCO2017728089. doi: 10.1200/JCO.2017.72.8089.
    PubMed     Abstract available


  62. BRINDLE KM, Izquierdo-Garcia JL, Lewis DY, Mair RJ, et al
    Brain Tumor Imaging.
    J Clin Oncol. 2017 Jun 22:JCO2017727636. doi: 10.1200/JCO.2017.72.7636.
    PubMed     Abstract available


  63. STURM D, Pfister SM, Jones DTW
    Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    J Clin Oncol. 2017 Jun 22:JCO2017730242. doi: 10.1200/JCO.2017.73.0242.
    PubMed     Abstract available


  64. DIAMANDIS P, Aldape KD
    Insights From Molecular Profiling of Adult Glioma.
    J Clin Oncol. 2017 Jun 22:JCO2017739516. doi: 10.1200/JCO.2017.73.9516.
    PubMed     Abstract available


  65. GROMMES C, DeAngelis LM
    Primary CNS Lymphoma.
    J Clin Oncol. 2017 Jun 22:JCO2017727602. doi: 10.1200/JCO.2017.72.7602.
    PubMed     Abstract available


    May 2017
  66. WINICK N, Devidas M, Chen S, Maloney K, et al
    Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 May 23:JCO2016714774. doi: 10.1200/JCO.2016.71.4774.
    PubMed     Abstract available


  67. LIM SM, Kim HR, Lee JS, Lee KH, et al
    Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
    J Clin Oncol. 2017 May 18:JCO2016713701. doi: 10.1200/JCO.2016.71.3701.
    PubMed     Abstract available


  68. CHALMERS A, Akerley W
    Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naive, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice.
    J Clin Oncol. 2017 May 8:JCO2017727255. doi: 10.1200/JCO.2017.72.7255.
    PubMed    


  69. KIM DW, Tiseo M, Ahn MJ, Reckamp KL, et al
    Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
    J Clin Oncol. 2017 May 5:JCO2016715904. doi: 10.1200/JCO.2016.71.5904.
    PubMed     Abstract available


    April 2017
  70. PAGLIARO LC
    Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    J Clin Oncol. 2017;35:1036-1040.
    PubMed     Abstract available


    March 2017
  71. BOWERS DC, Moskowitz CS, Chou JF, Mazewski CM, et al
    Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
    J Clin Oncol. 2017 Mar 24:JCO2016701896. doi: 10.1200/JCO.2016.70.1896.
    PubMed     Abstract available


    January 2017
  72. MAGNUSON WJ, Lester-Coll NH, Wu AJ, Yang TJ, et al
    Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    J Clin Oncol. 2017 Jan 23:JCO2016697144. doi: 10.1200/JCO.2016.69.7144.
    PubMed     Abstract available


  73. ZHOU L, Deng L, Lu Y
    Epidermal Growth Factor Receptor Mutations in Non-Small-Cell Lung Cancer With Brain Metastasis: Can Up-Front Radiation Therapy Be Deferred or Withheld?
    J Clin Oncol. 2017 Jan 23:JCO2016715706. doi: 10.1200/JCO.2016.71.5706.
    PubMed    


    December 2016
  74. MOLITORIS JK, Edelman MJ, Regine WF, Feigenberg SJ, et al
    Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016 Dec 28:JCO2016697227.
    PubMed    


  75. CLEMENT SC, Schouten-van Meeteren AY, Boot AM, Claahsen-van der Grinten HL, et al
    Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
    J Clin Oncol. 2016;34:4362-4370.
    PubMed     Abstract available


  76. CLOUGHESY T, Finocchiaro G, Belda-Iniesta C, Recht L, et al
    Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA M
    J Clin Oncol. 2016 Dec 5:JCO2015647685.
    PubMed     Abstract available


  77. WARDAK Z, Choy H
    Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016;34:4064-4065.
    PubMed    


  78. VON BUEREN AO, Kortmann RD, von Hoff K, Friedrich C, et al
    Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
    J Clin Oncol. 2016;34:4151-4160.
    PubMed     Abstract available


  79. GADGEEL SM, Shaw AT, Govindan R, Gandhi L, et al
    Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016;34:4079-4085.
    PubMed     Abstract available


    November 2016
  80. SULMAN EP, Ismaila N, Armstrong TS, Tsien C, et al
    Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
    J Clin Oncol. 2016 Nov 28:JCO2016707562.
    PubMed     Abstract available


  81. CHOI C, Raisanen JM, Ganji SK, Zhang S, et al
    Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.
    J Clin Oncol. 2016;34:4030-4039.
    PubMed     Abstract available


    July 2016
  82. CRINO L, Ahn MJ, De Marinis F, Groen HJ, et al
    Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.
    J Clin Oncol. 2016 Jul 18. pii: JCO655936.
    PubMed     Abstract available


  83. SCHMITZ N, Zeynalova S, Nickelsen M, Kansara R, et al
    CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
    J Clin Oncol. 2016 Jul 5. pii: JCO656520.
    PubMed     Abstract available


    April 2016
  84. COPUR MS, Ramaekers R, Clark D, Norvell M, et al
    Is It Time to Reconsider Prophylactic Cranial Radiation in Non-Small-Cell Lung Cancer?
    J Clin Oncol. 2016 Apr 25. pii: JCO652974.
    PubMed    


    March 2016
  85. GLASS J, Won M, Schultz CJ, Brat D, et al
    Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
    J Clin Oncol. 2016 Mar 28. pii: JCO648634.
    PubMed     Abstract available


  86. SOLOMON BJ, Cappuzzo F, Felip E, Blackhall FH, et al
    Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.
    J Clin Oncol. 2016 Mar 28. pii: JCO635888.
    PubMed     Abstract available


  87. KORFEL A, Schlegel U, Herrlinger U, Dreyling M, et al
    Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.
    J Clin Oncol. 2016 Mar 14. pii: JCO649897.
    PubMed     Abstract available


    January 2016
  88. BERNSTEIN LJ, Mason WP, Laperriere N, Chung C, et al
    Cognitive rehabilitation for brain tumor survivors: A pilot study.
    J Clin Oncol. 2016;34.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: